Recently, it was reported that Gdf11 gene transfer or recombinant GDF11 protein supplementation in rodents ameliorated high‐fat diet (HFD) induced obesity, hyperglycemia, insulin resistance, nonalcoholic fatty liver disease (NAFLD) and obesity.38, 39, 40. The gene discussed is GDF11; the disease is metabolic dysfunction-associated steatotic liver disease.